Goldman SachsGSTOP PICKJun 19, 2013Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
Normally, at the top of their cycle, they will trade at around 1.5-1.75 times Book and right now they are trading right around Book. Two things could be catalysts for this company. 1.) The volatility we are starting to see re-enter the market is good because they are good at trading. 2.) We will very likely see a capital markets surge with acquisitions, etc.